Gapping up
In reaction to strong earnings/guidance:
- FIVN +17.1%, SPWR +16.1%, TNK +14.6%, BOOT +11.9%, CROX +10.9%, RUBI +10.6%, TIVO +10.2%, CNCE +9.3%, ALSN +8.1%, RBBN +7.7%, VNDA +7.3%, TTMI +6.6%, BTI +6.5%, CRUS +6.2%, ACAD +6%, SHOP +6%, BAND +5.9%, AYX +5.6%, AR +5.4%, DBVT +5.4%, W +5.4%, WTI +5.3%, AJRD +5.3%, CMPR +5.2%, LPI +5.1%, HCC +5.1%, IGT +4.9%, ARGX +4.5%, BLDP +4.2%, YUM +4.1%, FICO +3.6%, CI +3.5%, MPLX +3.4%, WDC +3.2%, SKT +3.1%, ABC +3.1%, MCK +3%, AM +3%, HABT +3%, CTSH +2.9%, VEON +2.6%, SWIR +2.5%, PENN +2.5%, GNRC +2.3%, RPD +2.2%, IRM +2%, RGEN +2%, VRTX +1.7%, BCS +1.6%, WMB +1.5%, MPC +1.5%, BTE +1.3%, HBI +1.3%, TSLX +1.2%, VZ +1.2%, TDOC +1.1%, ZNGA +1.1%, BCE +1.1%, EXEL +1%, MT +0.9%
Select solar related names showing strength following SPWR earnings:
- RUN +2.9%, CSIQ +2.1%, FSLR +0.6%, JKS +0.5%
Other news:
- RES +10.8% (to join S&P SmallCap 600)
- ADPT +3% (ticking higher-receives New York CLEP approval for clonoSEQ Assay to detect and monitor MRD in patients with certain blood cancers)
- EXEL +1% (enters into exclusive agreement with Aurigene Discovery Technologies to discover and develop novel therapies for cancer)
Analyst comments:
- CCI +1.5% (upgraded to Overweight from Neutral at JP Morgan)
- IBM +0.6% (resumed with an Overweight at Morgan Stanley)